IL-25

Unknown Manufacturer

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Synergistic combination of immunologic inhibitors for the treatment of cancer
US 10034939 B2Applicant: UNIV CHICAGOPriority: 2012
US
WO
5 publications
ANTI-IL-25 ANTIBODIES AND METHODS OF USE THEREOF
EP 4687978 A1Applicant: NOVAROCK BIOTHERAPEUTICS LTDPriority: 2023
CN
EP
US
WO
4 publications
COMPOUNDS FOR INHIBITION OF IL-1BETA EXPRESSION
EP 4788811 A1Applicant: LEMBA BVPriority: 2023
CN
EP
US
WO
4 publications
Anti-IL-25 antibodies and uses thereof
US 9840557 B2Applicant: REGENERON PHARMAPriority: 2014
CN
US
4 publications
Methods for improving cognitive function
US 12440513 B2Applicant: ALBANY MEDICAL COLLEGEPriority: 2019
US
WO
4 publications
Lactococcus lactis producing TSLP or IL-25 and their uses as probiotics and therapeutics
US 10238697 B2Applicant: ARES TRADING SAPriority: 2015
CN
EP
US
3 publications
Anti-IL-25 antibodies and use thereof
US 12258392 B2Applicant: SUZHOU KANOVA BIOPHARMACEUTICAL CO LTDPriority: 2018
CN
EP
US
3 publications
Neutralizing monoclonal antibodies to IL-25 and uses thereof
US 11492397 B2Applicant: ABEOME CORPPriority: 2016
CN
US
3 publications
Novel Anti-Human IL-23 Receptor Antibody
US 2014275490 A1Applicant: OHORI MAKOTOPriority: 2011
CN
US
2 publications
Anti-IL-1beta antibodies
US 10344085 B2Applicant: HOFFMANN LA ROCHEPriority: 2014
CN
US
2 publications